Related Experiment Video

Updated: Aug 15, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
08:01

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology

Published on: March 22, 2012

Non-Aspergillus fungal pneumonia in transplant recipients

Sylvia F Costa1, Barbara D Alexander

  • 1Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.

Clinics in Chest Medicine
|November 3, 2005
PubMed

Insights

Opportunistic fungal infections are increasing due to a rise in immunocompromised patients. This article discusses emerging fungal pathogens causing pneumonia, highlighting their environmental prevalence and resistance to antifungals.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Immunocompromised Host Research

Background:

  • Invasive fungal infections (IFIs) are a significant cause of morbidity and mortality, particularly in immunocompromised individuals.
  • While Aspergillus and Candida species are historically dominant pathogens, a broader range of fungi are emerging as significant threats.
  • These emerging opportunistic fungi are often environmentally ubiquitous and exhibit reduced susceptibility to existing antifungal therapies.

Purpose of the Study:

  • To review the emergence of opportunistic fungi beyond Aspergillus and Candida as significant causes of IFIs.
  • To discuss the clinical implications of these emerging pathogens in the context of an increasing immunocompromised population.
  • To focus on fungal pneumonia as a key manifestation of these infections.

Main Methods:

  • Literature review of emerging fungal pathogens causing IFIs.
  • Analysis of clinical characteristics and epidemiological trends.
  • Discussion of antifungal resistance patterns.

Main Results:

  • Identification of several environmental fungi now recognized as opportunistic pathogens.
  • Association of these fungi with increased morbidity and mortality in immunosuppressed patients.
  • Highlighting diminished susceptibility to current antifungal agents as a critical challenge.

Conclusions:

  • The spectrum of fungal pathogens causing severe infections is expanding.
  • Opportunistic fungi pose a growing threat, necessitating enhanced diagnostic and therapeutic strategies.
  • Fungal pneumonia caused by these emerging agents requires specific attention and research.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...